S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

QNRX Quoin Pharmaceuticals Ltd

0.5865

-0.035 (-5.63%)

After Hours

Last Updated: 17:21:51

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Quoin Pharmaceuticals (NASDAQ:QNRX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Quoin Pharmaceuticals Charts.

Quoin Pharmaceuticals (NASDAQ:QNRX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Quoin Pharmaceuticals Charts.

Quoin Pharmaceuticals Ltd News

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials
Tuesday 7 January 2025 (6 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 6 January 2025 (1 week ago) • Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study
Monday 6 January 2025 (1 week ago) • GlobeNewswire Inc.

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Thursday 2 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Thursday 2 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 27 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 26 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Monday 23 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Sunday 22 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
Friday 20 December 2024 (3 weeks ago) • GlobeNewswire Inc.

More Quoin Pharmaceuticals Ltd News Articles

Credito Emilian

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions